Y. Okano

Dose-adjustment of lenalidomide according to patient age and vulnerability is feasible in relapsed or refractory multiple myeloma: retrospective analysis of 20 cases

S. Ito, T. Oyake, S. Kowata, 2014 .

Pretreatment evaluation of fluorescence resonance energy transfer‐based drug sensitivity test for patients with chronic myelogenous leukemia treated with dasatinib

J. Sakamoto, Y. Ohba, T. Nagashima, 2018, Cancer science.

Association of CD8 + T cells expressing nivolumab-free PD-1 with clinical status in a patient with relapsed refractory classical Hodgkin lymphoma

S. Ito, T. Oyake, S. Kowata, 2023, International Journal of Hematology.